Thyroid cancer is occasionally associated with hyperthyroidism. Papillary thyroid carcinoma is the most frequently reported histologic type followed by follicular thyroid carcinoma. Medullary ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Dr. Dr. med. Matthias Kroiß 1. Raue F, Bruckner T, Frank-Raue K: The Long-term cure of patients with hereditary medullary thyroid carcinoma: 40 years of follow-up in a single center. Dtsch ...

GREAT FALLS — Brennan Bogie just celebrated his 18th birthday, and he’s in a battle with a rare mutation of thyroid cancer.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The treatment is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with multiple endocrine neoplasia syndrome type 2. The once-weekly ...

If you have a personal or family history of thyroid cancer. Doctors usually will not prescribe Ozempic to people with a personal or family history of medullary thyroid cancer (MTC) or multiple ...

"For this reason, patients who have had, or have family members who have ever had medullary thyroid carcinoma should not use liraglutide, nor should patients who have an endocrine system condition ...

APS-03118 is under clinical development by Applied Pharmaceutical Science and currently in Phase II for Medullary Thyroid Cancer.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.